Q2 2018 EPS Estimates for DENTSPLY SIRONA Inc (XRAY) Decreased by William Blair

DENTSPLY SIRONA Inc (NASDAQ:XRAY) – Investment analysts at William Blair cut their Q2 2018 earnings per share (EPS) estimates for DENTSPLY SIRONA in a research note issued on Wednesday, July 11th. William Blair analyst J. Kreger now expects that the medical instruments supplier will earn $0.60 per share for the quarter, down from their previous forecast of $0.62. William Blair also issued estimates for DENTSPLY SIRONA’s Q3 2018 earnings at $0.71 EPS, Q4 2018 earnings at $0.83 EPS, FY2018 earnings at $2.58 EPS, Q1 2019 earnings at $0.55 EPS, Q2 2019 earnings at $0.73 EPS, Q3 2019 earnings at $0.76 EPS, FY2019 earnings at $2.84 EPS, FY2020 earnings at $3.13 EPS and FY2021 earnings at $3.45 EPS.

XRAY has been the subject of a number of other reports. ValuEngine cut shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Tuesday, May 8th. HC Wainwright set a $63.00 target price on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a research note on Tuesday, March 27th. Morgan Stanley lowered their target price on shares of DENTSPLY SIRONA from $65.00 to $54.00 and set an “overweight” rating for the company in a research note on Thursday, June 14th. Barclays reiterated a “hold” rating and issued a $55.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, May 8th. Finally, BidaskClub upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a research note on Wednesday, June 13th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and nine have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $61.42.

XRAY stock opened at $45.70 on Monday. The company has a market capitalization of $10.31 billion, a P/E ratio of 17.18, a P/E/G ratio of 2.35 and a beta of 1.23. The company has a quick ratio of 1.46, a current ratio of 2.23 and a debt-to-equity ratio of 0.25. DENTSPLY SIRONA has a 52 week low of $41.64 and a 52 week high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Sunday, May 6th. The medical instruments supplier reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.03. The company had revenue of $956.10 million during the quarter, compared to analysts’ expectations of $942.20 million. DENTSPLY SIRONA had a negative net margin of 38.32% and a positive return on equity of 8.63%. DENTSPLY SIRONA’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period last year, the business earned $0.49 EPS.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 12th. Shareholders of record on Friday, September 28th will be paid a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 0.77%. The ex-dividend date of this dividend is Thursday, September 27th. DENTSPLY SIRONA’s payout ratio is 13.16%.

In other DENTSPLY SIRONA news, Director Michael J. Coleman sold 6,038 shares of DENTSPLY SIRONA stock in a transaction that occurred on Friday, June 1st. The shares were sold at an average price of $43.97, for a total transaction of $265,490.86. Following the completion of the sale, the director now directly owns 26,960 shares in the company, valued at approximately $1,185,431.20. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Michael C. Alfano sold 1,404 shares of DENTSPLY SIRONA stock in a transaction that occurred on Wednesday, May 30th. The shares were sold at an average price of $45.83, for a total transaction of $64,345.32. Following the sale, the director now owns 13,458 shares of the company’s stock, valued at $616,780.14. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 7,856 shares of company stock valued at $349,153. Company insiders own 1.93% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in XRAY. MML Investors Services LLC increased its holdings in DENTSPLY SIRONA by 24.9% in the 4th quarter. MML Investors Services LLC now owns 4,529 shares of the medical instruments supplier’s stock worth $298,000 after acquiring an additional 904 shares in the last quarter. LPL Financial LLC increased its holdings in DENTSPLY SIRONA by 2.5% in the 4th quarter. LPL Financial LLC now owns 42,283 shares of the medical instruments supplier’s stock worth $2,783,000 after acquiring an additional 1,024 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in DENTSPLY SIRONA by 2.3% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 46,277 shares of the medical instruments supplier’s stock worth $2,328,000 after acquiring an additional 1,028 shares in the last quarter. Riverhead Capital Management LLC increased its holdings in DENTSPLY SIRONA by 17.4% in the 1st quarter. Riverhead Capital Management LLC now owns 7,661 shares of the medical instruments supplier’s stock worth $385,000 after acquiring an additional 1,136 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its holdings in DENTSPLY SIRONA by 13.8% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 11,739 shares of the medical instruments supplier’s stock worth $591,000 after acquiring an additional 1,424 shares in the last quarter. Institutional investors and hedge funds own 93.81% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: Understanding Analyst Recommendations

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply